Work

Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics

Year: 2022

Type: article

Study design: Clinical Trial

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.2778

Authors: Paula L. Hyland, Lakshmi Manasa S. Chekka, Deepti P. Samarth, Barry A. Rosenzweig, Erica Decker, Esraa G. Mohamed, Yan Guo, Murali K. Matta, Qin Sun, William Wheeler, Carlos Sanabria, James L. Weaver, Sarah J. Schrieber, Jeffry Florian, Yow‐Ming Wang, David G. Strauss

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research, Information Management Services, Spaulding Clinical Research (United States)

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4307582636

FWCI: 0.86

Cites: 36

Cited by: 10

Related to: 10